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Abstract: AIMS: The impact of exercise training on the right heart and pulmonary circulation has not
yet been invasively assessed in patients with pulmonary hypertension (PH) and right heart failure. This
prospective randomized controlled study investigates the effects of exercise training on peak VO2/kg,
haemodynamics, and further clinically relevant parameters in PH patients. METHODS AND RESULTS:
Eighty-seven patients with pulmonary arterial hypertension and inoperable chronic thrombo-embolic PH
(54% female, 56 ± 15 years, 84% World Health Organization functional class III/IV, 53% combination
therapy) on stable disease-targeted medication were randomly assigned to a control and training group.
Medication remained unchanged during the study period. Non-invasive assessments and right heart
catheterization at rest and during exercise were performed at baseline and after 15 weeks. Primary
endpoint was the change in peak VO2/kg. Secondary endpoints included changes in haemodynamics.
For missing data, multiple imputation and responder analyses were performed. The study results showed
a significant improvement of peak VO2/kg in the training group (difference from baseline to 15 weeks:
training +3.1 ± 2.7 mL/min/kg equals +24.3% vs. control -0.2 ± 2.3 mL/min/kg equals +0.9%, P <
0.001). Cardiac index (CI) at rest and during exercise, mean pulmonary arterial pressure, pulmonary
vascular resistance, 6 min walking distance, quality of life, and exercise capacity significantly improved
by exercise training. CONCLUSION: Low-dose exercise training at 4-7 days/week significantly improved
peak VO2/kg, haemodynamics, and further clinically relevant parameters. The improvements of CI
at rest and during exercise indicate that exercise training may improve the right ventricular function.
Further, large multicentre trials are necessary to confirm these results.
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Aims The impact of exercise training on the right heart and pulmonary circulation has not yet been invasively assessed
in patients with pulmonary hypertension (PH) and right heart failure. This prospective randomized controlled
study investigates the effects of exercise training on peak VO2/kg, haemodynamics, and further clinically relevant para-
meters in PH patients.
Methods
and results
Eighty-seven patients with pulmonary arterial hypertension and inoperable chronic thrombo-embolic PH (54% female,
56+ 15 years, 84% World Health Organization functional class III/IV, 53% combination therapy) on stable disease-
targeted medication were randomly assigned to a control and training group. Medication remained unchanged during
the study period. Non-invasive assessments and right heart catheterization at rest and during exercise were performed
at baseline and after 15 weeks. Primary endpoint was the change in peak VO2/kg. Secondary endpoints included changes
in haemodynamics. For missing data, multiple imputation and responder analyses were performed. The study results
showed a significant improvement of peak VO2/kg in the training group (difference from baseline to 15 weeks: training
+3.1+2.7 mL/min/kg equals +24.3% vs. control20.2+ 2.3 mL/min/kg equals +0.9%, P, 0.001). Cardiac index (CI)
at rest and during exercise, mean pulmonary arterial pressure, pulmonary vascular resistance, 6 min walking distance,
quality of life, and exercise capacity significantly improved by exercise training.
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Conclusion Low-dose exercise training at 4–7 days/week significantly improved peak VO2/kg, haemodynamics, and further clinic-
ally relevant parameters. The improvements of CI at rest and during exercise indicate that exercise training may
improve the right ventricular function. Further, large multicentre trials are necessary to confirm these results.
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Introduction
Previous studies in patients with idiopathic pulmonary arterial
hypertension (IPAH),1 – 5 inoperable chronic thrombo-embolic
pulmonary hypertension (CTEPH),6 associated PAH (APAH) in
connective tissue disease,7 and APAH in congenital heart disease8
have shown beneficial effects of exercise training as add-on to
disease-targeted medical therapy increasing exercise capacity and
quality of life (QoL).1,4,5 In four smaller studies, a randomized,
controlled trial design has been performed.1,3,5,9 These trials as-
sessed patients with IPAH and inoperable CTEPH and showed an
improvement of 6 min walking distance (6MWD), cardiorespiratory
function, fatigue, activity, and QoL parameters by exercise training.
In further prospective, uncontrolled trials, similar results have been
obtained and long-term follow-up revealed excellent 1- and 2-year
survival rates of 95–100% in the patients who had participated in
the training programme and continued training at home.4,6 – 8,10
The sample size of all these studies was relatively small (19–183
patients). Despite these limitations, the recommendation for this
thoroughly supervised rehabilitation including exercise training has
been upgraded to Class I, with a Level of Evidence of A within the
last world congress in Nice in 2013.11,12 This recommendation was
combined with the request to perform further randomized con-
trolled multicentre trials.12 The mechanisms for the improvement
of symptoms, exercise, and functional capacity and the possible
effects on prognosis are still not completely understood.
The improvement of muscle function such as increase in capillar-
ization and change of fibre type by exercise training2 has already
been shown in PH. There is also evidence that exercise training
influences the pulmonary vasculature,13 with a regulating effect on
pulmonary vascular remodelling. The effect of exercise training on
peak oxygen consumption (VO2/kg) is inconsistent in PH trials.
Few uncontrolled trials using exercise training in an outpatient
setting did not observe a significant improvement in VO2.
2,14,15
Up to now, there is no study investigating the effect of exercise
training on peak VO2/kg as primary endpoint, allowing a confirma-
tive conclusion. Furthermore, there is growing evidence that train-
ing may improve right ventricular (RV) function. Animal models
suggested a beneficial effect of training on the RV, such as a reduc-
tion of RV end-diastolic pressure and increase in RV capillary density
(+86%, P, 0.05).16,17
The effect of exercise training on cardiopulmonary function and
RV haemodynamics is of high interest and needs to be further as-
sessed using cardiopulmonary exercise testing (CPET) and right
heart catheterization (RHC) before and after training. Recent
publications have shown that peak oxygen uptake (VO2), cardiac in-
dex (CI),18 and systolic pulmonary arterial pressure during exercise
are important independent predictors for survival.19–21
Therefore, the aim of this study was to perform a large, prospect-
ive, randomized trial to investigate the impact of exercise training on
peak VO2 as an important prognostic factor in patients with severe
PAH or CTEPH and right heart failure. The study was also aimed to
provide first insights into the effects of exercise training on invasively
measured haemodynamics.
Methods
Study population and design
Patients with PAH and inoperable or persistent CTEPH and chronic
right heart failure who were stable on disease-targeted medication for
at least 2 months prior to inclusion were randomly assigned to a control
and a training group. Medication remained unchanged during the study
period. Clinical examinations including RHC were performed at baseline
and after 15 weeks. During the study, patients of the control group did
not receive any advice on exercise training (Figure 1).
All patients gave their written informed consent to the study. The
study was approved by the Ethics Committee of the University of
Heidelberg, Germany. The study was registered at clinicaltrials.gov
(NCT01394367).
Outcome measures
Primary endpoint was the change in peak VO2/kg. Secondary endpoints
were the change from baseline to 15 weeks in invasively measured
haemodynamics at rest and during symptom-limited exercise, 6MWD,
workload QoL questionnaire (SF-36), World Health Organization
(WHO) functional class, and N-terminal prohormone brain natriuretic
peptide (NT-proBNP). QoL questionnaires were analysed in a blinded
fashion. Patients in the control group went on with their usual lifestyle
during the study. Efficacy parameters were evaluated at baseline and
week 15, as described previously.1,10 Assessment of 6MWD, SF-36,
and other efficacy parameters were performed by investigators who
were blinded to the clinical data. Changes in WHO functional
class and Borg dyspnoea scale (with 6 representing no exertion and
20 maximal exertion)22 were also analysed. CPET was carried out as su-
pine cycle exercise, as described previously.1 Systolic and diastolic sys-
temic blood pressures, workload, heart rate, ventilation, and VO2 were
measured breath-by-breath. In patients dependent on long-term oxygen
therapy, oxygen supplementation was paused throughout and resup-
plied directly after termination of the test.
RHC was performed at baseline and 15 weeks. Patients were ex-
amined on a variable load supine cycle ergometer (model 8420; KHL
Corp., Kirkland, WA, USA). The examination at rest and during
symptom-limited exercise was performed in a supine position using
the transjugular approach with an 8F introducer set (MXI100, MEDEX,
Smiths Group Plc, UK). RHC was performed by triple-lumen
7F-Swan-Ganz thermodilution catheters (Edwards Lifesciences, Irvine,
CA, USA). Workload started at 25 W and was increased every 2 min
for 25 W until symptom-limited exercise capacity was reached. Cardiac
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output (CO) was measured at least in triplicate at rest and in duplicate at
the end of each workload during exercise by thermodilution with a vari-
ation of ,10% between the measured values. The zero reference point
for pressure recordings was set at the level of the right atrium in the
mid-axillary line (phlebostatic axis). All examinations and measurements
were performed by the same experienced team. There were no
complications.
Rehabilitation programme with exercise
training
The exercise and respiratory training was performed as described be-
fore1,10 and was started in-hospital for 3 weeks in the Rehabilitation
Clinic Ko¨nigstuhl in Heidelberg. We performed a programme especially
developed for PH patients with at least 1.5 h/day exercise training (in in-
tervals distributed over the day), consisting of interval cycle ergometer
training at low workloads at 7 days a week, walking, dumbbell training of
single muscle groups using low weights (500–1000 g), and respiratory
training at 5 days/week. The training was continued at home with at least
15 min/day at 5 days a week for the following 12 weeks.
Besides physical training, patients received mental training to improve
their perception of their individual physical abilities and limits. Psycho-
logical support was offered to all participants. The training programme
was closely supervised by physical therapists and physicians specialized
in rehabilitation medicine and by PH experts, as described before.1 Ad-
verse events were recorded whenever they occurred. Oxygen satur-
ation and heart rate were monitored continuously throughout the
training and were used to adjust the training intensity. When patients’
oxygen saturation fell below 90% during exercise, they received oxygen
supply (3–10 L/min) throughout the training. Patients who were on
oxygen therapy 16–24 h/day before inclusion into this study remained
on oxygen throughout the training programme. At discharge from hos-
pital after 3 weeks, patients received an individualized training manual
and ordered a cycle ergometer for use at home.
Statistical methods
The analyses were performed by two statisticians (N.E. and C.F.). Data
are given as mean values+ standard deviations. For the description of
effects, we present changes in absolute values and changes in per cent
of the individual baseline value.
Calculation of sample size was based on the primary efficacy end-
point, which was defined as the change in peak VO2/kg between baseline
and 15 weeks of exercise training. The null hypothesis to be assessed in
the confirmatory analysis states that there is no difference in the changes
of the peak VO2/kg value between the intervention and the control
group. To detect a placebo-adjusted difference in peak VO2/kg of
2 mL/min/kg, with a standard deviation of 3 mL/min/kg, with a power
of 80%, and a two-sided significance level of 5%, it was calculated that
45 patients were required in each treatment arm. Primary efficacy ana-
lysis was performed by an analysis of covariance (ANCOVA) model in-
cluding baseline values as covariate, thereby yielding a power advantage
over the standard t-test used for sample size calculation.
Figure 1 Study design. The flowchart shows the number of allocated patients for each treatment group, the number of patients valid for analysis,
and the number and reasons for exclusion, respectively (original data).
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The secondary endpoints were compared between groups by
an ANCOVA including baseline values as covariate. For analysis of
categorical data, the McNemar–Bowden test was used.
To include missing values, we performed two sensitivity analyses:
(i) multiple imputation analysis based on multiple regression models
with 20 imputed data sets and (ii) a responder analysis regarding missing
values and worsening of the parameters as non-responder. For the
multiple imputation analysis, the combined results are stated. Threshold
between response and non-response was set as 0. The responder
analysis with number/percentage of responders vs. non-responders
was performed by x2 test. All tests were two-sided, and P-values less
than 0.05 were considered statistically significant. All analyses were
carried out with IBM SPSS V20 (IBM Corp. Armonk, NY, USA).
Statement of responsibility
The authors had full access to the data and take full responsibility for its
integrity. All authors have read and agree to the manuscript as written.
Results
Study population and randomization
Ninety-five consecutive patients with invasively diagnosed PAH and
inoperable or persistent CTEPH under optimized medication
therapy were included (Figure 1). Eight patients were not eligible
for the study: one patient had an alteration in his/her medication,
two patients were not able to perform an ergometer test, and
five patients had an invalid ergometer test at baseline. Thus, the
study group consisted of 87 patients who were randomized into a
control and a training group (71% PAH, 29% CTEPH, 79% WHO
functional class III, 54% female, 56+15 years) (Figure 1 and Table 1).
The control and training groups did not differ in their baseline
characteristics, disease severity, or medication (Table 1).
Primary endpoint: change in peak
oxygen uptake
Peak VO2/kg significantly improved in the training group with
+3.1+ 2.7 mL/min/kg (baseline 13.3+ 3.6 mL/min/kg; mean in-
crease relative to baseline +24.3%) vs. 20.2+ 2.3 mL/min/kg
(baseline 12.7+ 4.0 mL/min/kg; mean increase relative to baseline
+0.9%) in the control group (P, 0.001; Figure 2 and Table 2). In
the training group, 91.7% of the patients reached a peak VO2/kg
of ≥11.5 mL/min/kg, compared with the control group with 50%.
Secondary endpoints
Haemodynamics and right heart function
RHC was performed at baseline and after 17+ 7.5 weeks in 74
of 87 (81.6%) patients: 34 patients of the training group and 40
patients of the control group agreed to invasive assessment of
haemodynamics by RHC. Haemodynamics at rest and during
exercise significantly improved in the training group, compared
with the control group (Figure 3). The measurements at rest
(Figure 3) revealed a significant improvement of CI (training +0.2+
0.6 L/min/m2; +9.3% vs. control 20.3+ 0.9 L/min/m2; 26.5%, P,
0.001), CO (training +0.7+ 0.9 L/min/m2; +12.5% vs. control
20.5+ 1.3 L/min/m2; 25.3%, P, 0.001), mean pulmonary arterial
pressure (mPAP) at rest (training 24+ 10 mmHg; 27.3% vs. con-
trol +4+ 8 mmHg; +16.1%, P ¼ 0.007), and pulmonary vascular
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Table 1 Baseline characteristics
Baseline characteristics Control Training
Patients, n 41 46
Gender, male/female 20/21 20/26
Age (years) 57+15 55+15
Height (cm) 171+8 170+9
Weight (kg) 79+18 75+18
WHO functional class, no. (%) baseline
II 6 (15%) 8 (18.2%)
III 30 (75%) 36 (81.8%)
IV 4 (10%) 0 (0%)
Diagnosis
Pulmonary arterial hypertension 26 (63.4%) 35 (76.1%)
CTEPH 15 (36.5%) 11 (23.9%)
NT-proBNP (pg/mL)
Baseline 1114+1386 1163+2520
Right heart catheterization
Mean pulmonary arterial pressure
(mmHg)
37.6+11.8 41.0+11.7
Pulmonary vascular resistance
(dyn × s /cm5)
512+338 540+267
Central venous pressure (mmHg) 7.1+4.7 7.5+3.7
Pulmonary arterial oxygen
saturation (%)
64.3+9.4 64.7+9.9
Pulmonary arterial wedge pressure
(mmHg)
9.4+3.8 9.4+3.5
Cardiac index (L/min/m2) 2.69+0.89 2.68+0.73
PAH-targeted medication
Endothelin receptor antagonists 29 (70.7%) 33 (71.7%)
Phosphodiesterase-5-inhibitors 30 (73.2%) 31 (67.4%)
Prostanoids inhaled 6 (14.6%) 3 (6.5%)
Prostanoids per os 0 (0%) 1 (2.2%)
Prostanoids intravenous 0 (0%) 0 (0%)
Calcium channel blockers 3 (7.3%) 5 (10.9%)
Imatinib 1 (2.4%) 0 (0%)
Soluble guanylate
cyclase-stimulator
3 (7.3%) 6 (13%)
Combination therapy
Monotherapy 14 (35%) 13 (33.3%)
Dual therapy 22 (55%) 20 (51.3%)
Triple therapy 4 (10%) 6 (15.4%)
Oxygen therapy, yes/no 20/21 17/25
Values are mean+ standard deviation.
For the category WHO functional class, values were missing for one patient in the
control group and two patients in the training group. For the category NT-proBNP
at baseline, values were missing for 12 patients in the control group. For the
categories mean pulmonary arterial pressure and pulmonary vascular resistance,
values were missing for seven patients in the control group and six patients in the
training group. For the category central venous pressure, values were missing for 10
patients in the control group and 8 in the training group. For the category pulmonary
artery oxygen saturation, 20 values were missing for the control group and 16 for the
training group. For the category pulmonary arterial wedge pressure, eight values
were missing for the control group and six for the training group. For the category
cardiac index, seven values were missing for both training and control groups.
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resistance (training 287+151 mmHg; 219.3% vs. control +87+
168 mmHg; +34.5%, P, 0.001) in the training group, compared
with the control group and baseline. P-values for multiple im-
putations are shown in Figure 3.
Measurements during exercise baseline vs. 15 weeks revealed a
significant improvement of CI during exercise (training +1.0+
1.4 L/min/m2; +19.5% vs. control 20.2+ 0.6 L/min/m2; 24.3%,
P ¼ 0.002; Figure 4) and further haemodynamic parameters in the
training group, compared with the control group (Figure 3 and
Table 2). Both time points were also analysed for the same work-
load, which corresponds either to the maximum of baseline or
follow-up examination. The analysis at the same workload showed
the same results with significant improvement of both CI and CO
during exercise (difference from baseline: CO training +1.41+
2.13 L/min vs. control 20.38+ 0.29 L/min, CI training +0.66+
1.06 L/min/m2 vs. control 20.23+ 0.66 L/min/m2, both P ¼ 0.001
for original data; for multiple imputation: both P ¼ 0.03 compared
with baseline and control).
Further clinical parameters
After 15 weeks of treatment, the 6MWD and change in the work-
load during CPET significantly improved in the training compared
with the control group (control group corrected change: 6MWD
+41 m, P ¼ 0.001 and CPET +19 W, P, 0.001; Figure 5 and
Table 2).
At baseline, all patients had significantly compromised QoL
scores compared with the general population. Only for the subscale
vitality, P-values were significant for both original data and multiple
imputation (for original data P ¼ 0.036 and for multiple imputation
P ¼ 0.042) (Figure 6).
For evaluation of WHO functional class, the prepared sheets
were not filled in by the investigators for .50% of the patients,
so this parameter was not analysed. NT-proBNP values varied large-
ly within the population at baseline also due to comorbidities such as
renal insufficiency and did not show a statistically significant differ-
ence between groups (training 979+ 2811 vs. control 1074+
1424; P ¼ 0.44). Echocardiography data showed no statistically sig-
nificant change in right heart areas and systolic pulmonary arterial
pressure between groups. Tricuspid annular plane systolic excur-
sion significantly decreased in the training group compared with
the control group.
Sensitivity analysis: responder vs.
non-responder
A sensitivity analysis was performed for primary and secondary end-
points treating missing values as non-responders. Change in work-
load (training 54% vs. control 21% responders, P ¼ 0.002), peak
VO2 (training 74% vs. control 44%, P ¼ 0.006), mPAP (training
64% vs. control 28%, P ¼ 0.001), CO (training 59% vs. control
23%, P ¼ 0.001), CI (training 51% vs. control 21%, P ¼ 0.005),
PVR (training 64% vs. control 26%, P ¼ 0.001), CO during exercise
(training 59% vs. control 21%, P ¼ 0.001), and CI during exercise
(training 56% vs. control 23%, P ¼ 0.003) remained statistically
significant.
Discussion
This large prospective, randomized, controlled trial evaluates the ef-
fect of exercise training on peak VO2/kg as primary endpoint and in-
vasively measured haemodynamics in patients with severe PAH and
Figure 2 Primary endpoint: change in peak oxygen uptake. Left graph: The abscissa shows peak VO2/kg at baseline, and the ordinate shows
change of peak VO2/kg from baseline after 15 weeks for each patient. The solid points represent patients of the training group, and the circles
represent patients of the control group. This graph shows equal distribution of baseline peak VO2 in both groups as well as changes after 15 weeks
of exercise training. Change in peak VO2 did not correlate with baseline peak VO2. Right graph: the boxplots at the right side show median change
of VO2 max in the control vs. training group after 15 weeks. A significant increase can be shown in the training group (P, 0.001), whereas the
control group shows a small reduction in peak VO2 after 15 weeks. Multiple imputations showed the same P-value.
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Table 2 Change echocardiography, CPET, and haemodynamics
Characteristics Training group Control group P-value
Baseline Change from baseline to 15 weeks Baseline Change from baseline to 15 weeks
Primary analysis set (n 5 79: 38 training vs. 41 control) Absolute Change in per cent
(95% confidence
interval)
Absolute Change in per cent
(95% confidence
interval)
ANCOVA
Mean 6 min walking distance (m) 453+91 29+53 5.5 (1.7, 9.3) 413+95 212+46 21.9 (26, 2.25) 0.002
Laboratory parameters
NT-proBNP (pg/mL) 1163+2520 289+1387 13.2 (29, 35) 1114+1386 141+827 39.9 (221, 101) 0.44
Cardiopulmonary exercise testing
Peak VO2/kg (mL/min/kg) 13.3+3.6 3.1+2.7 24.3 (17.1, 31.4) 12.7+4.0 20.2+2.3 0.9 (26.4, 8.3) ,0.001
Peak VO2 (mL/min) 986+294 233+209 23.2 (16.6, 30) 992+275 228+150 22.4 (27, 2.2) ,0.001
Oxygen pulse [(mL/min)/min21] 8.2+2.4 0.6+1.1 7.4 (3.5, 11.2) 8.0+2.1 0.1+1.1 1.5 (22.3, 5.3) 0.07
HR rest (1/min) 74+11 2+10 3.8 (20.8, 8.4) 80+11 24+11 24.8 (28.8, 20.8) 0.18
HR max (1/min) 122+21 14+15 12.8 (8, 17.7) 125+17 24+12 22.8 (25.9, 0.2) ,0.001
RR sys at rest (mmHg) 114+18 25+17 23.0 (27.4, 1.4) 111+15 2+16 2.6 (22, 7.2) 0.19
RR dia at rest (mmHg) 72+10 22+11 21.1 (25.6, 3.4) 74+10 22+11 21.3 (26.1, 3.6) 0.78
RR sys max (mmHg) 140+22 13+24 10.7 (4.3, 17.1) 146+25 23+23 20.2 (25, 4.6) 0.008
RR dia max (mmHg) 82+12 3+14 6.0 (20.8, 12.7) 79+13 2+11 3.6 (20.8, 8.0) 0.34
Workload max (W) 74+27 18+28 32.1 (15.8, 48.4) 72+23 21+14 1.8 (26.4, 10.1) ,0.001
Secondary analysis set (n ¼ 59: 31 training vs. 28 control)
RHC at rest
mPAP (mmHg) 41+12 24+10 27.3 (213.2, 21.5) 38+12 5+8 16.1 (6.4, 25.8) 0.007
Cardiac output (L/min) 5.0+1.4 0.7+0.9 12.5 (6.3, 18.6) 5.1+1.8 20.5+1.3 25.3 (211.7, 1.1) ,0.001
Cardiac index (L/min/m2) 2.7+0.7 0.2+0.6 9.3 (2.4, 16.2) 2.7+0.9 20.3+0.8 26.5 (213, 0.2) ,0.001a
PAWP (mmHg) 9+4 2+4 24.4 (9.2, 39.7) 9+4 20.3+4.7 9.2 (212, 30) 0.18
PVR (dyn × s/cm) 540+267 287+151 219.3 (228.4, –10.3) 512+338 87+168 34.5 (1, 68) ,0.001a
RHC during exercise (exercise n ¼ 49: 28 training vs. 21 control)
mPAP (mmHg) 66+19 2+10 5.3 (20.2, 10.8) 58+18 4+9 9.6 (0.7, 18.6) 0.71
Cardiac output (L/min) 10.3+3.4 2.1+2.7 20.4 (11.5, 29.2) 9.1+2.3 20.3+1.2 22.0 (29, 5) 0.002
Cardiac index (L/min/m2) 5.4+1.6 1.0+1.4 19.5 (10.4, 28.5) 4.7+1.1 20.2+0.6 24.3 (212, 3) 0.002
PAWP (mmHg) 15+5 0.6+6 9.7 (27.5, 26.9) 15+7 0.5+4 7.1 (24, 19) 0.93
PVR (dyn × s/cm5) 453+219 244+150 210.6 (222.3, 1.1) 439+272 26+175 15.1 (26, 37) 0.16
Values are mean+ standard deviation; two-sided P-values of ANCOVA are given.
NT-proBNP, N-terminal pro-B-type natriuretic peptide; PAP, pulmonary arterial pressure; sys, systolic; dia, diastolic; m, mean; HR, heart rate; RR, blood pressure; TAPSE, tricuspid annular plane systolic excursion; RHC, right heart catheter;
PAWP, pulmonary arterial wedge pressure; PVR, pulmonary vascular resistance.
aNo significant difference in multiple imputation analysis. Frequency of missing values within the analysis sets within groups was always below 15%.
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inoperable or persistent CTEPH. To the best of our knowledge,
there is only one previous publication performing RHC after training
in 20 patients with left heart failure.23 The results of the study
showed an improvement of peak VO2/kg, CI, and CO during exer-
cise, suggesting that this treatment might improve RV function.
Other prognostic parameters such as CI at rest, pulmonary vascular
resistance, mPAP, 6MWD, QoL parameters, and exercise capacity
significantly improved in the training group. Bearing in mind that
these effects were reached as add-on in patients with optimized
medical treatment, low-dose exercise training was very effective.
Effect on peak oxygen uptake and
RV function
The results of this study confirm previous findings that exercise
training improves peak VO2/kg in patients with severe PH by ap-
proximately 15–25%.1,4,7,8,10 Study results that did not show posi-
tive effects of exercise training on peak VO2/kg
2,14,15 may be
evoked by less intensive training due to an outpatient setting and
by a lower training frequency of three times a week or less. Peak
VO2 is linearly associated with RV function.
24,25 Both were severely
Figure 3 Secondary endpoints: haemodynamic function. Results from RHC for mean pulmonary arterial pressure (A), pulmonary vascular re-
sistance (B), cardiac output (C) and cardiac index (D) at rest. The graphs depict the change of each parameter in per cent from baseline to 15 weeks
after exercise training/no training. The mean changes of the training group, compared with baseline and control, as absolute values are given at the
top of each graph with corresponding P-values of the ANCOVA for original data and multiple imputations. The bars are representing two times
standard error.
Figure 4 Haemodynamics during exercise. The distribution
of absolute changes in CI during exercise (P, 0.001) is shown
by a boxplot for each group. The training group improved CI
by 19.5%, whereas the control group had a decrease of 4.3%.
P-values are given for the ANCOVA for original data and multiple
imputations.
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Figure 5 6MWD. The figure shows the absolute changes in 6MWD for each patient: patients of the training group as solid lines and patients of
the control group as dashed lines. Mean changes are given with darker lines, and error bars indicate +1 standard error of the mean. Exercise
training significantly improved 6MWD compared with baseline (P ¼ 0.002). P-values are given for the ANCOVA for original data and multiple
imputations.
Figure 6 QoL. Mean changes of QoL+2 standard errors of the mean and sample sizes below each bar. The bars of the control group are
shown on the left side of each category. Exercise and respiratory training significantly improved the subscale score for vitality (P ¼ 0.036), com-
pared with the control group, in which this parameter slightly worsened. The subscales role limitations due to physical restrictions (P ¼ 0.099),
role limitations due to emotional restrictions (P ¼ 0.09), and general health perception (0.091) were significant in trend in the original data, but
showed inconsistent findings in multiple imputation.
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reduced in our patients at rest and during exercise. RV dysfunction is
a crucial factor contributing to functional impairment and mortality.
Improvement of peak VO2/kg is possibly due to improvement of ca-
pillary density of the skeletal muscle, which has been identified
before in patients with IPAH.2
CI and CO significantly improved at rest, during maximal ex-
ercise, and when comparing the baseline and follow-up assessments
at the same workload. The improvements in haemodynamics at
rest and during exercise point out that training may also be benefi-
cial for the RV function, which is a strong prognostic predictor in
these patients.19,20,26,27 CI during exercise has recently been
detected to be the most important independent haemodynamic
predictor of survival in PH in the investigated cohort,18,20 correlated
well with the clinical data, and was even more informative than
haemodynamics at rest.
Mechanism of exercise training in athletes
and patients with left heart failure
Previous studies in healthy athletes have shown that endurance
exercise training causes a significant increase in skeletal muscle
capillarization, characterized by an elevated capillary density and
capillary-to-fibre ratio.28 – 30 The physiological adaptation con-
tributes to enhanced aerobic capacity by increased transport, con-
ductance, and extraction of oxygen in skeletal muscles. In patients
with left heart failure, exercise training has shown to improve
ventilatory efficiency,31 the reversal of skeletal muscle atrophy,32
the attenuation of endothelial dysfunction,33 and inflammatory
mediators.34– 36 Besides these ‘peripheral effects’ on skeletal muscle
function, it is not known yet whether there is a direct effect of
exercise training on the heart muscles. Erbs et al.37 showed im-
provement of left ventricular ejection fraction, stroke volume, and
CO at peak exercise after 12 weeks of exercise training in patients
with advanced chronic left heart failure.24 Wisloff et al.38 reported
that after 12 weeks of aerobic-moderate continuous training and
aerobic-intense interval training, left ventricular ejection fraction
of cardiac patients increased. This study confirmed the effects of
exercise training by invasive measurements of pulmonary circulation
in patients with PAH/CTEPH and right heart failure.
Limitations
RHC was an optional assessment in this study. Thus, a referral bias
may have occurred as only 83% of the patients received RHC. The
haemodynamic effects of this study may therefore serve as first re-
sults to plan prospective, randomized studies on the effects of exer-
cise training on haemodynamics at rest and during exercise. The
training group showed a significant increase in heart rate during ex-
ercise when compared with the control group. This may be a hint
for a higher volitional effort. However, haemodynamics also showed
a significant improvement when examinations were compared for
the same workload.
In a randomized controlled trial, a responder analysis does not re-
flect a worst-case scenario and is therefore not appropriate as a
mere sensitivity analysis. The findings of both responder analysis
and multiple imputations, however, showed almost the same signifi-
cant parameters as the original data analysis.
NT-proBNP values, which are associated with disease progres-
sion, showed no statistical difference between changes of control
and training groups. This may also be influenced by the large vari-
ation of values, as in six patients NT-proBNP was highly increased
due to renal insufficiency.
It is a general issue of exercise training studies that they cannot be
performed in a blinded fashion and that a referral bias towards highly
motivated patients with a better outcome may occur.
Conclusion
This prospective, randomized, controlled trial confirms that low-
dose exercise training at 4–7 days/week as add-on to PAH-targeted
medication significantly improves peak VO2. The study indicates that
exercise training improves cardiopulmonary parameters such as
pulmonary vascular resistance and CI at rest and during exercise,
leading to an increase in exercise capacity and QoL. The results of
the study suggest that this therapy can improve RV function and
other important prognostic parameters. The precise mechanism
through which exercise-based interventions benefit PH patients still
remains unclear. Further, larger multicentre trials using CI during
exercise and time to clinical worsening as primary endpoints are
necessary to confirm these results and to assess the impact of this
therapy on patient outcomes.
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